Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
New cancer gene therapy data have been reported by scientists at University of Birmingham
March 18th, 2008
New investigation results, 'Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma,' are detailed in a study published in British Journal of Cancer. According to recent research published in the British Journal of Cancer, "Promoter region hypermethylation and transcriptional silencing is a frequent cause of tumor suppressor gene (TSG) inactivation in many human cancers. Previously, to identify candidate epigenetically inactivated TSGs in renal cell carcinoma (RCC), we monitored changes in gene expression in four RCC cell lines after treatment with the demethylating agent 5-azacytidine." "This...
Source: Cancer Weekly (2008-03-18)
|
